CD8A and neoplasm: We observed that NKp30+CD8+ T cells effectively killed the tumor cells regardless of the expression of MHC-class I at the cell surface, while HER2TCR+NKp30−CD8+ T cells could only kill tumor cells expressing MHC-class I (Figure 4(c)).